Maxillofacial hemangiomas have a fairly high incidence, accounting for about 50% of infantile hemangiomas. Hemangiomas (capillary hemangiomas and infantile hemangiomas) are somewhat self-limiting in their development, but larger tumors that grow rapidly can break down and bleed, become infected and scarred, severely damaging the child’s facial appearance and causing lifelong disfigurement. Sudden hemorrhage can be caused by trauma, infection or no obvious reason, even leading to life-threatening hemorrhagic shock. Moreover, the treatment of maxillofacial giant hemangioma with hormone, isotope and photochemical methods is ineffective. Because the lesions are deep, progressive, and involve a large area; in addition, they are rich in blood vessels, so if surgical treatment is used for these lesions, it is extremely difficult to remove a large area, trauma, and blood loss, and the postoperative tissue loss is serious, and although a large area of tissue transplantation is performed, it can still cause facial disfigurement. Local injection treatment is ineffective and has high side effects due to rapid blood flow. Therefore, it is extremely difficult to treat maxillofacial hemangioma with traditional methods. With the development of science and technology in recent years, catheter material technology and interventional treatment level have made rapid progress, and interventional treatment for infants and children with maxillofacial hemangioma has become mature, with unparalleled advantages of other treatments. The femoral artery is punctured with a special puncture kit for children, and the blood supply artery of the hemangioma is super-selectively cannulated with the 3F microcatheter system. Pingyangmycin iodine oil emulsion is injected directly into the lesioned vessel of the hemangioma through the catheter, and the blood supply artery is embolized, so that the tumor is completely cured under the dual effects of pingyangmycin to remove blood vessels and embolization to cause ischemia. Interventional treatment of giant maxillofacial hemangioma through femoral artery cannulation has the advantages of no scar on the face, remarkable efficacy, less trauma, quick recovery, short hospitalization time and no recurrence, etc., and is becoming more and more popular among families of children.